iShares Genomics Immunology and Healthcare ETF – AMEX:IDNA
iShares Genomics Immunology and Healthcare ETF stock price today
$22.55
-0.27
-1.23%
Market closed
Open in 21 minutes
iShares Genomics Immunology and Healthcare ETF stock price monthly change
-7.23%
month
iShares Genomics Immunology and Healthcare ETF stock price quarterly change
-7.23%
quarter
iShares Genomics Immunology and Healthcare ETF stock price yearly change
-1.59%
year
iShares Genomics Immunology and Healthcare ETF key metrics
Market Cap | 140.21M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeiShares Genomics Immunology and Healthcare ETF stock price history
iShares Genomics Immunology and Healthcare ETF stock forecast
iShares Genomics Immunology and Healthcare ETF financial statements
iShares Genomics Immunology and Healthcare ETF other data
Horiba: Wonderful Japanese Company At A Very Attractive Price
Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
Ginkgo Bioworks: Promising Upside But Not Without Risks
CytoDyn: It Only Takes One Hit
Coherus: 2022 Is In Many Ways A Make Or Break Year
Can Intellia One-Up Alnylam In Transthyretin Amyloidosis?
Selecta: ImmTOR Could Change Autoimmune Disorder Treatment Landscape
SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play
-
What's the price of iShares Genomics Immunology and Healthcare ETF stock today?
One share of iShares Genomics Immunology and Healthcare ETF stock can currently be purchased for approximately $22.55.
-
When is iShares Genomics Immunology and Healthcare ETF's next earnings date?
Unfortunately, iShares Genomics Immunology and Healthcare ETF's (IDNA) next earnings date is currently unknown.
-
Does iShares Genomics Immunology and Healthcare ETF pay dividends?
Yes, iShares Genomics Immunology and Healthcare ETF pays dividends and its trailing 12-month yield is 0.68% with 0% payout ratio. The last iShares Genomics Immunology and Healthcare ETF stock dividend of $0.26 was paid on 26 Sep 2025.
-
How much money does iShares Genomics Immunology and Healthcare ETF make?
iShares Genomics Immunology and Healthcare ETF has a market capitalization of 140.21M.
-
What is iShares Genomics Immunology and Healthcare ETF's stock symbol?
iShares Genomics Immunology and Healthcare ETF is traded on the AMEX under the ticker symbol "IDNA".
-
What is iShares Genomics Immunology and Healthcare ETF's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of iShares Genomics Immunology and Healthcare ETF?
Shares of iShares Genomics Immunology and Healthcare ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When iShares Genomics Immunology and Healthcare ETF went public?
iShares Genomics Immunology and Healthcare ETF is publicly traded company for more then 6 years since IPO on 14 Jun 2019.
iShares Genomics Immunology and Healthcare ETF company profile:
Exchange:
AMEX
Full time employees:
0
Industry:
Asset Management
Sector:
Financial Services
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
,
CIK: 0001100663
ISIN: US46435U1925
CUSIP: 46435U192
